SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Imclone systems (IMCL)
IMCL 0.1590.0%Oct 5 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cacaito who wrote (2073)2/20/2002 4:19:10 PM
From: 613  Read Replies (2) of 2515
 
You make good points. But IMCL says they have the evidence to prove most if not all of the data the FDA requests.

But, in general, wouldn't a cancer drug that even works 10% of the time be useful for an otherwise 100% deadly disease. I think CEGE is working on a vaccine that is targetted to the patient. The patient is biopsied and the tumor is tested (?) in the lab to detect/design the proper drug. Perhaps this could be done with Erbitux and other potential cancer drugs too.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News